BLOSSOMHILL THERAPEUTICS
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.
BLOSSOMHILL THERAPEUTICS
Social Links:
Industry:
Biopharma Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2020-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.bhtherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
71 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Cytocom
Cytocom is a biopharmaceutical company focused on analogs that treat multiple diseases.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Interius BioTherapeutics
Interius BioTherapeutics is a biopharmaceutical company developing a paradigm-shifting platform for in vivo cell-specific gene delivery.
KeChow Pharma
KeChow Pharma, Inc. is a biopharmaceutical company focused on novel drug discovery.
Monopar
Monopar Therapeutics is an emerging biopharmaceutical company focused on developing orphan oncology compounds.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Simcha Therapeutics
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.
Wren Therapeutics
Wren Therapeutics is a biopharmaceutical company based, focused on drug discovery and development for protein misfolding diseases.
XinThera
XinThera is a drug discovery company focused on building small molecule oncology and immunology pipeline.
Current Advisors List
Current Employees Featured
Founder
Investors List
Hercules Bioventure Partners
Hercules Bioventure Partners investment in Series A - BlossomHill Therapeutics
OrbiMed
OrbiMed investment in Series A - BlossomHill Therapeutics
Vivo Capital
Vivo Capital investment in Series A - BlossomHill Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series A - BlossomHill Therapeutics
Official Site Inspections
http://www.bhtherapeutics.com
Unable to get host informations!!!
More informations about "BlossomHill Therapeutics"
About | BlossomHill Therapeutics
May 28, 2024 Dr. J. Jean Cui has a prolific track record as a cancer drug designer and developer. Three molecules designed by Dr. Cui have become market-approved medicines, including repotrectinib (AUGTYRO ®), crizotinib …See details»
BlossomHill Therapeutics - Crunchbase Company …
Contact Email [email protected] BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders. Products and ServicesSee details»
BlossomHill Therapeutics, Inc. | LinkedIn
BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.See details»
Careers | BlossomHill Therapeutics
We are a science-forward organization led by our luminary, Dr. Jean Cui, and we welcome all to traverse mountains, ridges, rivers and streams to BlossomHill and solve treatment resistance. Join Us. Stay Connected for Future Opportunities. …See details»
BlossomHill Therapeutics - PitchBook
Www.bhtherapeutics.com. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. 3525 John Hopkins Court; Suite 100; San Diego, CA 92121; United StatesSee details»
BlossomHill Therapeutics, founded by a former Pfizer chemist
Feb 29, 2024 Jean Cui, a former Pfizer chemist, has raised $173 million from a coalition of top biotech investors for her new company, BlossomHill Therapeutics.See details»
BlossomHill Therapeutics Chief Executive Officer, Jingrong Jean …
SAN DIEGO, February 14, 2024--BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating cancer and autoimmune …See details»
BlossomHill Therapeutics - VentureRadar
"BlossomHill Therapeutics, Inc. is a small molecule drug discovery and development company focused on unmet medical needs in oncology and autoimmune disorders.See details»
Series B - BlossomHill Therapeutics - 2024-01-02 - Crunchbase
Jan 2, 2024 Organization Name . BlossomHill Therapeutics . Announced Date Jan 2, 2024; Closed On Date Feb 29, 2024; Funding Type Series B; Funding Stage Early Stage Venture; …See details»
BlossomHill Therapeutics Closes $100 Million Series B Financing
SAN DIEGO, Calif., February 29, 2024--BlossomHill Therapeutics, Inc., a biotechnology company focused on the design and development of small molecule medicines for treating cancer and …See details»
BlossomHill Therapeutics Chief Executive Officer, Jingrong
Feb 14, 2024 SAN DIEGO--(BUSINESS WIRE)-- BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating …See details»
BlossomHill Therapeutics Chief Executive Officer ... - Business Wire
Feb 14, 2024 SAN DIEGO--(BUSINESS WIRE)--BlossomHill Therapeutics, a biotechnology company focused on the design and development of small molecule medicines for treating …See details»
BlossomHill Therapeutics Closes $100 Million Series B Financing
Feb 29, 2024 SAN DIEGO, Calif.--(BUSINESS WIRE)-- BlossomHill Therapeutics, Inc., a biotechnology company focused on the design and development of small molecule medicines …See details»
Clinical Trials | BlossomHill Therapeutics
If you have any questions about our investigational drugs or clinical trials, please contact [email protected]. Timing of Acknowledgment BlossomHill Therapeutics, Inc. …See details»
Blossomhill Therapeutics - Overview, News & Similar ... - ZoomInfo
Blossomhill Therapeutics contact info: Phone number: (858) 732-3880 Website: www.bhtherapeutics.com What does Blossomhill Therapeutics do? Blossomhill Therapeutics …See details»
BlossomHill Therapeutics Closes $71M Series A Financing
SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced …See details»
Pipeline | BlossomHill Therapeutics
We are evaluating a potentially better way to treat EGFR-positive NSCLC. BH-30643 is a mutant-selective OMNI-EGFR ™ inhibitor with an aim to provide greater benefit to patients by:. Super …See details»
Bihua Chen | BlossomHill Therapeutics
Bihua Chen founded Cormorant Asset Management, LP (“Cormorant”), an investment firm focused on innovative biotech, MedTech and life science companies with more than $3 billion …See details»
Discovery of BH-30236: A Novel Macrocyclic CLK Inhibitor …
Contact: [email protected] 1. Bradley R, Anczuków O. RNA splicing dysregulation and the hallmarks of cancer. Nat Rev Cancer. 2023;23(3):135-155 Note: PIM447 is a proxy …See details»